Overview

Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects

Status:
Completed
Trial end date:
2017-11-13
Target enrollment:
Participant gender:
Summary
Phase 1 study in healthy subjects to determine the effect of rifampin (Part A) or itraconazole (Part B) on the pharmacokinetics of BGB-3111
Phase:
Phase 1
Details
Lead Sponsor:
BeiGene
Treatments:
Hydroxyitraconazole
Itraconazole
Rifampin
Zanubrutinib